PRESS RELEASE published on 01/11/2024 at 14:00, 1 year 11 months ago Pluralytics Delivers Patented Generative AI Solution to Microsoft Users Pluralytics, a generative AI writing solution, announced its new Microsoft Add-In that empowers writers to predict and analyze content language for deeper audience engagement. The Add-In enables users to choose audience, tones, analyze text affinity, calculate alignment score, and improve language. Current customers see up to 30% increase in language affinity. Pluralytics focuses on scientific precision to generate resonating language with measurable engagement increases while maintaining unique brand voice. Pluralytics Microsoft Add-In Generative AI Writing Audience Engagement Language Science
Published on 12/18/2025 at 00:55, 2 hours 13 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 8 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 3 hours 53 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 8 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 8 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 1 hour 57 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 2 hours 17 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 3 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 3 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 5 hours 45 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 6 hours 28 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 6 hours 28 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 7 hours 38 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 8 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025